Trial intelligence / Profile preview

Botox for Sialorrhea in ALS

NCT01551940Phase 2Completed

Sponsor
Hospices Civils de Lyon
Start
Feb 2012
Primary completion
Mar 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in sialorrhea, sponsored by Hospices Civils de Lyon. Started Feb 2012; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

sialorrhea

Beyond the preview

Go deeper on NCT01551940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01551940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call